Preparing for economic downturn, investors turn to private equity. Mergers & Acquisitions profiles the top U.S. PE firms, including Gentstar. Novartis completes spinoff of Alcon, plus deals from Macquarie, Stanadyne.
Novartis buys Endocyte, snapping up a potential blockbuster therapy for prostate cancer. FedEx buys Australian logistics company. Now that cannabis is legal in Canada, what should U.S. private equity firms do?
